Literature DB >> 11446393

Survival patterns among HIV+ individuals based on health care utilization.

K J Welch1, A Morse.   

Abstract

The purpose of this study was to determine if HIV+ persons who first obtained health care in New Orleans through public hospital inpatient services had a higher risk of death or disease progression than patients who first entered care through public outpatient services. The sites included the largest HIV outpatient clinic in the Gulf South, two early intervention sites and a public hospital. A medical record review on patients who attended these sites from July 1995 through December 1999 and were enrolled in the Adult Spectrum of Disease (ASD) Study was conducted (n = 3402). The multivariate analysis examined the associations between inpatient services and the main effects. Kaplan-Meier analysis and Cox proportional hazards regression were performed. Risk of death or disease progression was analyzed for three different endpoints: time from study entry to death, time from HIV to AIDS, and time from AIDS to death. The multivariate analysis showed that patients first entering care through inpatient services were significantly more likely to be African American, have AIDS, and use drugs. The risk of death or disease progression was significantly higher for all three endpoints. Results from this study indicate that HIV+ individuals receiving initial care through public hospital inpatient services may require more effective early intervention.

Entities:  

Mesh:

Year:  2001        PMID: 11446393      PMCID: PMC2594027     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  15 in total

1.  A survival analysis of hospitalization among patients with acquired immunodeficiency syndrome.

Authors:  C P Quesenberry; B Fireman; R A Hiatt; J V Selby
Journal:  Am J Public Health       Date:  1989-12       Impact factor: 9.308

2.  Correlates of alcohol and/or drug use among HIV-infected individuals.

Authors:  K J Welch
Journal:  AIDS Patient Care STDS       Date:  2000-06       Impact factor: 5.078

3.  Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators.

Authors:  F J Palella; K M Delaney; A C Moorman; M O Loveless; J Fuhrer; G A Satten; D J Aschman; S D Holmberg
Journal:  N Engl J Med       Date:  1998-03-26       Impact factor: 91.245

4.  A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team.

Authors:  S M Hammer; K E Squires; M D Hughes; J M Grimes; L M Demeter; J S Currier; J J Eron; J E Feinberg; H H Balfour; L R Deyton; J A Chodakewitz; M A Fischl
Journal:  N Engl J Med       Date:  1997-09-11       Impact factor: 91.245

5.  Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy.

Authors:  R M Gulick; J W Mellors; D Havlir; J J Eron; C Gonzalez; D McMahon; D D Richman; F T Valentine; L Jonas; A Meibohm; E A Emini; J A Chodakewitz
Journal:  N Engl J Med       Date:  1997-09-11       Impact factor: 91.245

6.  Impact of clarithromycin and azithromycin on patterns of treatment and survival among AIDS patients with disseminated Mycobacterium avium complex.

Authors:  D V Ives; R B Davis; J S Currier
Journal:  AIDS       Date:  1995-03       Impact factor: 4.177

7.  Factors influencing survival after AIDS: report from the Multicenter AIDS Cohort Study (MACS).

Authors:  A J Saah; D R Hoover; Y He; L A Kingsley; J P Phair
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1994-03

8.  The effects of immune status and race on health service use among people with HIV disease.

Authors:  J D Piette; V Mor; K Mayer; S Zierler; T Wachtel
Journal:  Am J Public Health       Date:  1993-04       Impact factor: 9.308

9.  Predictors of survival in patients with AIDS and disseminated Mycobacterium avium complex disease.

Authors:  C R Horsburgh; B Metchock; S M Gordon; J A Havlik; J E McGowan; S E Thompson
Journal:  J Infect Dis       Date:  1994-09       Impact factor: 5.226

10.  Compliance with public sector HIV medical care.

Authors:  P Kissinger; D Cohen; W Brandon; J Rice; A Morse; R Clark
Journal:  J Natl Med Assoc       Date:  1995-01       Impact factor: 1.798

View more
  6 in total

1.  Race and sexual identity: perceptions about medical culture and healthcare among Black men who have sex with men.

Authors:  David J Malebranche; John L Peterson; Robert E Fullilove; Richard W Stackhouse
Journal:  J Natl Med Assoc       Date:  2004-01       Impact factor: 1.798

2.  Social support networks and primary care use by HIV-infected drug users.

Authors:  Megha Ramaswamy; Patricia J Kelly; Xuan Li; Karina M Berg; Alain H Litwin; Julia H Arnsten
Journal:  J Assoc Nurses AIDS Care       Date:  2012-08-04       Impact factor: 1.354

3.  Gender disparities in HIV health care utilization among the severely disadvantaged: can we determine the reasons?

Authors:  Nancy L Sohler; Xuan Li; Chinazo O Cunningham
Journal:  AIDS Patient Care STDS       Date:  2009-09       Impact factor: 5.078

4.  Assessment of a medical outreach program to improve access to HIV care among marginalized individuals.

Authors:  Chinazo O Cunningham; John Paul Sanchez; Daliah I Heller; Nancy L Sohler
Journal:  Am J Public Health       Date:  2007-08-29       Impact factor: 9.308

5.  Delivering care out of the box: the evolution of an HIV harm reduction medical program.

Authors:  Pamela A Mund; Daliah Heller; Paul Meissner; David W Matthews; Michael Hill; Chinazo O Cunningham
Journal:  J Health Care Poor Underserved       Date:  2008-08

6.  Medical and support service utilization in a medical program targeting marginalized HIV-infected individuals.

Authors:  Chinazo O Cunningham; John-Paul Sanchez; Xuan Li; Daliah Heller; Nancy L Sohler
Journal:  J Health Care Poor Underserved       Date:  2008-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.